Serum arylesterase and paraoxonase activities in patients with ovarian tumors

Abstract Objective High levels of toxic reactive oxygen species have been found in many types of cancer cells. Serum arylesterase (ARE) and paraoxonase (PON) are esterase enzymes that have strong antioxidant characteristics. The main purpose of our study was to evaluate the activity of ARE and PON i...

Full description

Saved in:
Bibliographic Details
Published in:Taiwanese journal of obstetrics & gynecology 2014-12, Vol.53 (4), p.490-493
Main Authors: Michalak, Slawomir, Szubert, Sebastian, Moszynski, Rafal, Sajdak, Stefan, Szpurek, Dariusz
Format: Article
Language:English
Subjects:
arylesterase
Internal Medicine
Obstetrics and Gynecology
ovarian cancer
oxidative stress
paraoxonase
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Objective High levels of toxic reactive oxygen species have been found in many types of cancer cells. Serum arylesterase (ARE) and paraoxonase (PON) are esterase enzymes that have strong antioxidant characteristics. The main purpose of our study was to evaluate the activity of ARE and PON in the sera of patients with ovarian cancer and benign ovarian tumors. Materials and methods This study included 30 patients with ovarian cancer, 42 patients with benign ovarian tumors, and 19 healthy age- and sex-matched individuals. ARE and PON activities were measured using spectrophotometry. Results Serum ARE activity was significantly different among the three studied groups ( p < 0.0001). However, posthoc tests revealed that ARE activity was lower in the benign ovarian tumor group (median, 1.53 U/mL; range, 0.43–2.47 U/mL) than in the other groups. There were no differences in ARE activity between patients with ovarian cancer (1.89 U/mL; range, 1.01–2.56 U/mL) and healthy individuals (2.05 U/mL; range, 0.79–2.44 U/mL). We found no differences in PON activity or the PON:ARE activity ratio between the studied groups. Tumor size in the benign ovarian tumor group was positively correlated with ARE activity (R Spearman = 0.46, p = 0.003) and negatively correlated with PON activity (R Spearman = −0.50, p = 0.001). The ARE and PON activities were not influenced by histological type, ovarian cancer grade, or disease advancement. Conclusion ARE activity is higher in patients with ovarian cancer than in patients with benign ovarian tumors; however, the serum activity of ARE is similar between patients with cancer and healthy individuals.
ISSN:1028-4559
DOI:10.1016/j.tjog.2013.08.009